Kathy Wolski
Cleveland Clinic · 270 works · 33,574 citations · h-index 73
Top works
- Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
- Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
- Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis
- Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
- Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
- Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.
- Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
- Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis
- Effect of Two Intensive Statin Regimens on Progression of Coronary Disease
- Bariatric Surgery Versus Intensive Medical Therapy in Obese Patients With Diabetes
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk
- Rosiglitazone Revisited
- Ticlopidine Pretreatment Before Coronary Stenting Is Associated With Sustained Decrease in Adverse Cardiac Events
- Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease
- Intravascular Ultrasound-Derived Measures of Coronary Atherosclerotic Plaque Burden and Clinical Outcome
- Smartwatch Algorithm for Automated Detection of Atrial Fibrillation
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
- Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity
- Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
- Mortality at 1 Year With Combination Platelet Glycoprotein IIb/IIIa Inhibition and Reduced-Dose Fibrinolytic Therapy vs Conventional Fibrinolytic Therapy for Acute Myocardial Infarction